Navigation Links
Exenatide Once Monthly Showed Positive Results in Phase 2 Study
Date:3/10/2011

emic control," said Christian Weyer, M.D., senior vice president, research and development, Amylin Pharmaceuticals. "Based on the encouraging results of this study, we plan to proceed with regulatory interactions to outline the next steps for this important program."

More than 90 percent of patients overall completed the study. The most common adverse events among the exenatide once monthly treatment groups were headache and nausea. Headache and diarrhea were most common among the once-weekly BYDUREON group. No major or minor hypoglycemia was reported in the study.

Exenatide once monthly is a new, extended-release formulation of exenatide, the active ingredient in BYETTA® (exenatide) injection, which is given twice daily. Exenatide once monthly is based on the same Medisorb® microsphere technology used in BYDUREON.

Study Design

This phase 2, randomized, open-label study included 121 adults with type 2 diabetes who were not achieving adequate glucose control using diet and exercise alone or with a stable regimen of metformin, Actos® (pioglitazone), or both.  Subjects were randomized to receive either 2 mg weekly subcutaneous injections of BYDUREON or subcutaneous injections of exenatide once monthly at a low, medium or high dose, each administered once every four weeks, for a total of 20 weeks.

About Diabetes

Diabetes affects nearly 26 million people in the U.S. and an estimated 285 million adults worldwide.(i, ii)  Approximately 90-95 percent of those affected have type 2 diabetes. Diabetes costs approximately $174 billion per year in direct and indirect medical expenses.(iii)

According to the Centers for Disease Control and Prevention's National Health and Nutrition Examination Survey, approximately 60 percent of people with diabetes do not achieve their target blood sugar levels with their current treatment regimen.(iv) In addition, 85 percent of type 2 diabetes patients are
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. New Data From Head-to-Head Phase 3 Trial Demonstrate That Liraglutide is More Effective Than Exenatide in Treatment of Type 2 Diabetes
2. Lilly and Amylin Enter Into Supply Agreement for Exenatide Once Weekly
3. Exenatide Clinical Data Analysis Shows No Increased Risk of Cardiovascular Events
4. Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes
5. New Drug Application for Exenatide Once Weekly Accepted for Review by FDA
6. Amylin and Lilly to Present More than 20 Studies for Exenatide at EASD 2009
7. Human Genome Sciences Announces Initiation of Phase 2b Trial of Albuferon(R) Dosed Monthly in Chronic Hepatitis C
8. Human Genome Sciences Announces Completion of Enrollment in Phase 2b Monthly-Dosing Trial of Albuferon(R)
9. BioProcess International Launches Monthly Asia-Pacific eNewsletter
10. Technology PR Boutique Launches PRTechConnect to Help Tech Startups Restart Economy with Industry's First $999 Monthly Service
11. RSB Spine, LLC, Announces Record Second-Quarter 2010 Revenue and Monthly Sales Milestone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 2014 OMICS Group’s 5th International conference ... August, 2014 at Double Tree by Hilton Beijing, China ... in Analytical & Bioanalytical research methods only to facilitate ... this occasion, Dr. Srinubabu Gedela, MD of OMICS Group ... a remarkable one in bringing a unique and international ...
(Date:7/10/2014)... 2014  Kainos Capital, a firm specializing in acquiring ... it has acquired the Slim-Fast brand from Unilever. Unilever ... of the transaction were not disclosed. Slim-Fast ... that markets ready-to-drink shakes, powders, bars and snacks to ... and in the United Kingdom ...
(Date:7/10/2014)... Adelaide research may help in the fight against terrorism ... tiny quantities of explosives with the use of light ... Sensors and Actuators B: Chemical , the researchers ... explosives in concentrations as low as 6.3 ppm (parts ... a few minutes. , "Traditionally explosives detection has involved ...
(Date:7/10/2014)... RICHLAND, Wash. The lithium-ion batteries that power our ... run longer on a single charge with the help ... the porous material to replace the graphite traditionally used ... more than 10 times the energy storage capacity of ... lithium-ion battery electrode was published today in Nature ...
Breaking Biology Technology:A Critical Review of Analytical Techniques for Improved Living Standards 2A Critical Review of Analytical Techniques for Improved Living Standards 3A Critical Review of Analytical Techniques for Improved Living Standards 4Kainos Capital Acquires Slim-Fast From Unilever 2Detecting trace amounts of explosives with light 2Silicon sponge improves lithium-ion battery performance 2Silicon sponge improves lithium-ion battery performance 3
... , MOUNTAIN VIEW, Calif., Aug. 26 ... a special meeting of stockholders held today, its stockholders approved the ... to purchase shares of the Company,s common stock to Symphony Capital ... completed its acquisition of Symphony Allegro, and as a result, Alexza ...
... , , , ... ) and Terrabon, L.L.C., today announced an agreement by Waste Management ... is the leading provider of comprehensive waste management and environmental services ... Management joins Valero Energy Corporation (NYSE: VLO ), the ...
... a valuable source of biofuel. Researchers writing in BioMed ... have shown that the juice of reject watermelons can ... with a team of researchers at the USDA-Agricultural Research ... US, to evaluate the biofuel potential of juice from ...
Cached Biology Technology:Alexza Stockholders Approve Share Issuance to Symphony Capital and Alexza Completes Acquisition of Symphony Allegro 2Alexza Stockholders Approve Share Issuance to Symphony Capital and Alexza Completes Acquisition of Symphony Allegro 3Alexza Stockholders Approve Share Issuance to Symphony Capital and Alexza Completes Acquisition of Symphony Allegro 4Waste Management and Terrabon Announce Investment Agreement for Waste-To-Fuel Conversion Technology 2Waste Management and Terrabon Announce Investment Agreement for Waste-To-Fuel Conversion Technology 3Waste Management and Terrabon Announce Investment Agreement for Waste-To-Fuel Conversion Technology 4
(Date:7/10/2014)... Amyloid diseases, such as Alzheimer,s disease, type ... share the common trait that proteins aggregate into ... vitro studies have found that neither the amylin ... toxic. New evidence using two-dimensional infrared (2D IR) ... amylin aggregation pathway that may explain toxicity, opening ...
(Date:7/10/2014)... Geostationary Operational Environmental Satellite or GOES-West satellite spotted ... fires raging in Canada,s Northwestern Territories. , At ... 2014, GOES-West captured this image of the brownish-colored ... Territories that drifted all the way into South ... GOES Project at NASA Goddard Space Flight Center, ...
(Date:7/10/2014)... MDBrightFocus Foundation, a nonprofit organization funding cutting-edge, innovative ... of glaucoma and macular degeneration, today announced the ... 55 scientists in 19 U.S. states, the District ... http://www.brightfocus.org/Grants2014 . , With these latest grants, ... in research funding in 2014. , The research ...
Breaking Biology News(10 mins):New technology reveals insights into mechanisms underlying amyloid diseases 2BrightFocus Foundation announces 55 new grantees in Alzheimer's and vision research 2BrightFocus Foundation announces 55 new grantees in Alzheimer's and vision research 3
... in the brain that help make HIV disease incurable, scientists ... biological vacuum cleaner that prevents anti-HIV drugs from reaching the ... HIV. They describe the advance, which allows medications to cross ... the Journal of the American Chemical Society . ...
... 12 October 2011, Singapore A new biotech ... of Singapore (NUS), to provide research tools, targeting the ... has been founded by two NUS faculty members: Dr ... Dr Kevin Tan from the NUS Department of Microbiology. ...
... carbon dioxide than it can bind. Local variations have increased the ... a study of how carbon dioxide flows between the water of ... the University of Gothenburg, Sweden. "The capacity of the ... acidity of the water has changed in recent centuries. In the ...
Cached Biology News:Launch of BioLynx provides a boost for the international malaria research community 2The Baltic Sea contributes carbon dioxide to the atmosphere 2
casein kinase 2, alpha 1 polypeptide, transcript variant 2, mRNA (cDNA clone MGC:15232 IMAGE:4121882), complete cds...
...
UV LAMP 300 NM 8W T5, 1 EA. Category: Nucleid Acid Detection Systems....
MOUSE ANTI S. MUTANS PEPTIDOGLYCAN...
Biology Products: